Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-HPV Vaccine and Surgery in Early Cervical Cancer
NCT00002916Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 1996
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 2 trial of TA-HPV in Cervical Cancer (CC), sponsored by European Organisation for Research and Treatment of Cancer. Started Nov 1996; status: completed.
02
Drugs
TA-HPV
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00002916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002916.